tbuckley/cabot-search huggingface dataset:
EP13.01-002 Radiomic Signature on CT Images: A Noninvasive Biomarker for Pretreatment Discrimination of EGFR Mutations in NSCLC Patients
Authors: Y. Kahya, K. Orhan, E.U. Buyukceran, E. Gumustepe, H. Ozakinci, E.B. Koksoy, F. Ibrahimov, S. Baloglu, A. Gursoy Coruh, S. Akyurek, S. Dizbay Sak, A. Kayi Cangir
Journal: Journal of Thoracic Oncology (2022)
EP08.02-034 OCELOT - Osimertinib then Chemotherapy in EGFR+ Lung Cancer with Osi Third-line Rechallenge and Osimertinib for Uncommon EGFRm in 1L
Authors: D. Breadner, G. Liu, J. Rothenstein, P. Wheatley-Price, P. Bains, S. Cheng, Y. Wang, S. Sun, H. Mithoowani, R. Juergens, P. Cheema, M. Vincent
Journal: Journal of Thoracic Oncology (2022)
EP08.01-028 Overestimation with Cox HR - Cox-TEL-Adjusted Associations of PD-L1 Expression with Immune Checkpoint Inhibitor Survival Benefit in Lung Cancer
Authors: E.P.-Y. Lin, C.-Y. Hsu, J.-F. Chiou, L. Berry, L. Horn, P. Bunn, J.C.-H. Yang, P.-C. Yang, A. Adjei, Y. Shyr
Journal: Journal of Thoracic Oncology (2022)
EP08.01-109 TACTI-002: A Phase II Study of Eftilagimod Alpha (Soluble LAG-3) &amp; Pembrolizumab in 2nd line PD-1/PD-L1 Refractory Metastatic NSCLC
Authors: M. Forster, M. Krebs, M. Majem, J. Peguero, T. Clay, E. Felip, W. Iams, P. Roxburgh, B. Doger, P. Bajaj, J. Kefas, J.-.A. Scott, A. Barba Joaquín, C. Mueller, F. Triebel
Journal: Journal of Thoracic Oncology (2022)
EP08.02-161 An Exploratory Study on Biomarkers Related to Primary Resistance Of EGFR-TKIs Therapy in Lung Cancer
Authors: L. Wu, J. Wang, B. Chen, X. Pu, J. Li, L. Liu, Q. Wang, Y. Xu, L. Xu, F. Xu, K. Li
Journal: Journal of Thoracic Oncology (2022)
EP08.02-018 Phase 1/2 Study of BLU-451, a Small Molecule Inhibitor of EGFR, in EGFR Exon 20 Insertion-Mutant Incurable Advanced Cancers
Authors: A. Spira, H. Yu, L. Sun, D. Nguyen, J. Parepally, F. Albayya, S. Patel, H. Zhang, A. Zalutskaya, X. Le
Journal: Journal of Thoracic Oncology (2022)
EP08.03-003 Surgery for Primary Tumor is Associated with Prolonged Overall Survival in Patients with Oligometastatic NSCLC
Authors: J.F. Corona-Cruz, O.A. Ruiz-Felix, E. Jimenez-Fuentes, M. Arroyo-Hernandez, F. Maldonado-Magos, L.A. Cabrera-Miranda, M. Ramos-Ramirez, P.D. Soberanis-Piña, O. Arrieta
Journal: Journal of Thoracic Oncology (2022)
EP08.02-174 RET Fusions as Primary Oncogenic Drivers and Secondary Acquired Resistance to EGFR TKI in a Large Cohort of Non-Small-Cell Lung Cancers
Authors: C. Wang, Z. Zhang, M. Wu, J. Yin, X. Wu, Y. Shao, P. Hou
Journal: Journal of Thoracic Oncology (2022)
EP08.02-060 How Do Oncologists Treat Patients With EGFR Exon-20 Mutant NSCLC Outside of Clinical Trials? Updated Analysis From the European EXOTIC Registry
Authors: G. Mountzios, D. Planchard, G. Metro, D. Tsiouda, A. Prelaj, S. Lampaki, W. Shalata, M. Riudavets, P. Christopoulos, N. Girard, V. Albarran, R. Garcia Campelo, K. Samitas, G. Banna, I. Boukovinas, A. Agbarya, A. Koumarianou, E.-I. Perdikouri, P. Kosmidis, M. Reck, G. Lo Russo
Journal: Journal of Thoracic Oncology (2022)
EP16.02-018 Liquid Biopsies First to Make Treatment Decisions in Patients With Metastatic Non-small Cell Lung Cancer (NSCLC)
Authors: L.E. Raez, K. Brice, J. Tsai, L. Drusbosky, K. Dumais, A. Lopez-Cohen, D. Wietecha, H. Daba, P. Izquierdo, E.S. Santos, H. Powery
Journal: Journal of Thoracic Oncology (2022)
EP14.05-005 Survival of Small Cell Lung Cancer in Relation to Chemotherapy Dose Intensity
Authors: E.M. Fernández Pérez, J. Fuentes Pradera, M. Fernández Carcaño, S. García Rodríguez, I. Beltrán Guerra, G. Lourenzo Aguilera, C. Ayala de Miguel, S. Díaz López, L. Bachurin, G. García González, M. Chaves Conde
Journal: Journal of Thoracic Oncology (2022)
EP08.02-127 Resistance Mechanisms to Osimertinib in Advanced EGFR-mutated NSCLC: A Single Institution Prospective Cohort Study
Authors: B.-C. Liao, C.-Y. Yang, T.-H. Tsai, W.-Y. Liao, K.-Y. Chen, C.-C. Ho, J.-Y. Shih, C.-J. Yu, J.C.-H. Yang
Journal: Journal of Thoracic Oncology (2022)
EP16.03-016 Targetable Alterations in Non-Small Cell Lung Cancer According to Age and Sex
Authors: E. Kimbrough, H. Dada, L.M. Drusbosky, D. Yang, J.A. Marin-Acevedo, A. Mooradian, Y. Zhao, R. Manochakian, Y. Lou
Journal: Journal of Thoracic Oncology (2022)
EP08.02-163 Real-World Case Series on Efficacy and Safety of Amivantamab for EGFR-mutant Non-small Cell Lung Cancer
Authors: X. Le, R. Du, W.E. Lewis, L. Hong, F. Skoulidis, L. Byers, A. Tsao, T. Cascone, J. Pozadzides, J. Tu, M.V. Negrao, C. Baik, J. Zhang, J. Heymach
Journal: Journal of Thoracic Oncology (2022)
EP08.02-168 Efficacy, Safety and Treatment Courses for Patients with ALK Oncogene Positive NSCLC; Retrospective Data in Single Institute
Authors: Y. Akazawa, A. Yoshikawa, K. Hashimoto, M. Ishijima, M. Kanazu, Y. Yano, M. Mori, T. Yamaguchi, J. Uchida
Journal: Journal of Thoracic Oncology (2022)
EP14.03-003 Phase I Study of Palliative Radiotherapy with Lurbinectedin in Patients with Extensive Stage Small Cell Lung Cancer
Authors: N.S. Mccall, J.M. Switchenko, S. Tian, W.A. Stokes, S. Kahn, A.H. Kesarwala, J.W. Shelton, S.M. Szabo, C.E. Steuer, J.W. Carlisle, S.S. Ramalingam, J.D. Bradley, T. Leal, K.A. Higgins
Journal: Journal of Thoracic Oncology (2022)
EP08.02-036 Selpercatinib Striking Response in a Case of Cerebral and Auditory Canal Metastasis of RET Fusion-Positive Non-Small-Cell Lung Cancer
Authors: D. Sousa, M. Afonso, D. Rocha, A. Craveiro, S. Martins, J. Barata, M.L.S. Valente
Journal: Journal of Thoracic Oncology (2022)
EP08.01-057 Pembrolizumab Maintenance in Patients with Metastatic Squamous Non-Small Cell Lung Cancer (sNSCLC) - AIO-TRK-0115/PRIMUS
Authors: M. Reck, J. Kollmeier, J. Kern, P. Hoffknecht, M. Sebastian, A. Tufman, K. Kambartel, R. Keller, M. Maenz, P. Sadjadian
Journal: Journal of Thoracic Oncology (2022)
EP08.02-121 The Landscape of Anti-neoplastic Drugs for Malignant Pleural Effusion in Non-small Cell Lung Cancer: A Systematic Review of Clinical Trials
Authors: O. Ababneh, Y. Ahmed, S. Syaj, Z. Hatamleh, S. Saleh, A. Zaitoun, M. Akhdar, M. Alsaid Ahmad, R. Al-shadiafat, S. Hamouri
Journal: Journal of Thoracic Oncology (2022)
EP08.01-096 Lung Immune Prognostic Index is Prognostic in Patients Treated with PD-1 Inhibitor Combined with Chemotherapy for Non-small Cell Lung Cancer
Authors: A. Xiong, J. Xu, S. Wang, Y. Shen, J. Lu, T. Chu, W. Zhang, Y. Li, B. Han, W. Nie, X. Zhang
Journal: Journal of Thoracic Oncology (2022)
EP11.01-012 Genomic Landscape of Liquid Biopsy in Advanced Lung Cancer Patients, an Indian Experience
Authors: S. Sharma, A. Aggarwal, T.N. Bhardwaj, S.K. Sharma, R. Katara, A. Kumar, A. Negi, D. Sharma, S.K. Mohanty
Journal: Journal of Thoracic Oncology (2022)
EP16.01-025 Immune Evolution of Metastases &amp; Underlying Molecular Mechanisms in Non-small Cell Lung Cancer
Authors: W.-F. Tang, R. Fu, X.-J. Fan, H. Bao, M. Wu, X. Wu, Y. Shao, Z.-B. Qiu, J. Su, Y.-L. Wu, Y. Liang, W.-Z. Zhong
Journal: Journal of Thoracic Oncology (2022)
EP16.02-024 Plasma ctDNA Organ-Specific Genomic Patterns and Origination Analysis in Advanced Non-Small Cell Lung Cancer
Authors: R. Fu, W.-F. Tang, L.-L. Yang, M. Wu, H. Bao, Y. Shao, C. Zhang, H.-Z. Hong, Y.-L. Wu, W.-Z. Zhong
Journal: Journal of Thoracic Oncology (2022)
EP16.03-012 Novel Human-derived EML4-ALK Fusion cell lines identify ribonucleotide reductase RRM2 as a Target of Activated ALK in NSCLC
Authors: G. Umapathy, A. Bokhari, W.-Y. Lai, A. Le, T.-P. Chuang, S. Fransson, T. Martinsson, J. Van den Eynden, R. Doebele, R.H. Palmer, B. Hallberg
Journal: Journal of Thoracic Oncology (2022)
EP08.02-148 Extended Follow-up of Efficacy and Safety of Larotrectinib in Patients With TRK Fusion Lung Cancer
Authors: V. Moreno, J.J. Lin, D.S.W. Tan, S. Kummar, M.-S. Dai, U.N. Lassen, S. Leyvraz, Y. Liu, J.D. Patel, L. Rosen, B. Solomon, J. Yachnin, R. Norenberg, M. Fellous, C.E. Mussi, L. Shen, A. Drilon
Journal: Journal of Thoracic Oncology (2022)
EP16.04-002 Combining Patient-Derived Xenografts and Barcoding Technology to Evaluate Response to Targeted Therapies in ALK+NSCLC
Authors: A. Petzold, P. Dujardin, S. Oeck, M. Wiesweg, B. Hegedüs, M. Schuler, B. Grüner, A. Schramm
Journal: Journal of Thoracic Oncology (2022)
EP14.03-002 Low-Dose Radiotherapy Plus Sugemalimab in Second-Line Treatment for Advanced-Stage Small-Cell Lung Cancer: Initial Results of a Phase I Study
Authors: y. Gong, Y. Liu, L. Zhou, R. Tong, F. Na, J. Xue, Y. Xu, B. Zou, Y. Zhang, F. Peng, J. Zhu, M. Yu, Y. Li, M. Huang, Y. Lu
Journal: Journal of Thoracic Oncology (2022)
EP16.03-020 High Tumor Mutational Burden by Whole-Genome Sequencing in Resected NSCLC in Never Smokers is Associated with Worse Prognosis
Authors: L.-J. Ruel, Z. Li, N. Gaudreault, C. Henry, V.S. Armero, D.K. Boudreau, T. Zhang, M.T. Landi, C. Labbé, C. Couture, P. Desmeules, P. Joubert, Y. Bossé
Journal: Journal of Thoracic Oncology (2022)
EP16.03-037 Poor Prognosis of Patients with EGFR Mutations Left behind by Selective Detection in NSCLC
Authors: T. Matsubara, E. Nakajima, I. Takada, T. Ohira, Y. Yazaki, T. Miyazaki, J. Matsubayashi, K. Furukawa, N. Ikeda
Journal: Journal of Thoracic Oncology (2022)
EP08.02-049 A Phase I Trial of the HER2 Exon 20 Inhibitor, BI 1810631, In Patients With Advanced Solid Tumors With HER2 Aberrations
Authors: F. Opdam, J. Heymach, M. Barve, N. Gibson, B. Sadrolhefazi, J. Serra, N. Yamamoto, K. Yoh, Y.-L. Wu
Journal: Journal of Thoracic Oncology (2022)
EP08.02-020 Preclinical Activity of NVL-655 in a Patient-Derived NSCLC Model with Lorlatinib-Resistant ALK G1202R/T1151M Mutation
Authors: H. Mizuta, L. Bigot, A. Tangpeerachaikul, H. Pelish, L. Friboulet
Journal: Journal of Thoracic Oncology (2022)
EP16.03-040 Biomarkersatlas.com: the Italian NSCLC Precision Medicine Knowledge Data Base
Authors: U. Malapelle, F. Pepe, P. Pisapia, L. Righi, A. Listì, M.L. Reale, F. Passiglia, M. Tiseo, C. Genova, D. Galetta, D. Cortinovis, S. Pilotto, M.R. Migliorino, H. Soto Parra, F. Cappuzzo, S. Novello, G. Troncone
Journal: Journal of Thoracic Oncology (2022)
EP08.02-033 Anlotinib in Elderly Patients With Advanced Non-squamous NSCLC Who Had Not Received Systemic Chemotherapy: A Single-Arm, Phase II Study
Authors: None d. zhao, None x. hou, Z. Li, X. Hou, L. Yang, H. Li, Z. Li, L. Yan, H. Liu, X. Liu, G. Li, F. Song, Y. Zhang
Journal: Journal of Thoracic Oncology (2022)
EP08.01-078 Clinical Outcomes in Metastatic Non-small Cell Lung Cancer Harboring BRAF Mutations Treated With Immune Checkpoint Inhibitors
Authors: D. Garcia-Illescas, A. Callejo, P. Iranzo, J.D. Assaf, G. Molina, I. Priano, A. Valdivia, N. Pardo, A. Navarro, A. Martinez-Marti, S. Cedres, C. Carbonell, J. Frigola, R. Amat, E. Felip
Journal: Journal of Thoracic Oncology (2022)
EP08.01-090 Association of Gender and Outcomes in Patients With Advanced NSCLC Treated With Immunotherapy Alone or in Combination With Chemotherapy Upfront
Authors: J. Torres Jiménez, T. Gorria, E. Auclin, N. Castro, V. Albarrán-Artahona, J.C. Ruffinelli, D. Pinato, B. Routy, F. Aboubakar Nana, R. Reyes, N. Viñolas, F. Blanc-Durand, G. Lopes, E. Nadal, H. Arasanz, M. Pascal, C. Teixidó, B. Besse, N. Reguart, L. Mezquita, J. Torres Jiménez
Journal: Journal of Thoracic Oncology (2022)
EP16.01-011 PD-L1 Expression on Cytological Imprints and Circulating Tumor Cells versus Standardized Immunohistochemistry in NSCLC
Authors: M. Abdo, Y. Belloum, D. Heigener, L. Welker, M. Schmidt, N. Heuer-Olewinski, H. Elmas, S. Perner, H. Wikman, K. Pantel, M. Reck
Journal: Journal of Thoracic Oncology (2022)
EP16.01-007 Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
Authors: P. Cruz Castellanos, R. Rosas Alonso, I. Ozaez, I. Hernández, I. Losantos, L. Gutiérrez Sainz, O. Higuera Gómez, C. Rodríguez Antolín, I. Esteban Rodríguez, I. Ibáñez de Cáceres, J. De Castro Carpeño
Journal: Journal of Thoracic Oncology (2022)
EP08.01-105 Efficacy of First-Line Immune Checkpoint Inhibitors in Patients with Advanced NSCLC harboring KRAS, MET, FGFR, RET, BRAF, and HER2 Alterations
Authors: Y. Uehara, K. Watanabe, M. Yomota, Y. Hosomi
Journal: Journal of Thoracic Oncology (2022)
EP11.01-007 Tracking ROS1 Fusions in NSCLC - Mirage or Truth When Screening the Desert
Authors: J. Mattsson, V. Thurfjell, T. Goldmann, R. Krupar, H. Brunnström, K. Lamberg, M. Gulyas, J. Botling, P. Micke
Journal: Journal of Thoracic Oncology (2022)
EP16.03-019 Landscape of EGFR Extracellular Domain Mutations in Advanced Non Small Cell Lung Carcinoma
Authors: S.R. Solomon, C.R. McDougall, J.R. Tsai, S.W. Myers, H.I. Dada, L.M. Drusbosky, L.A. Kiedrowski, C.M. Lovly
Journal: Journal of Thoracic Oncology (2022)
EP16.03-044 Genomic Evidence Depicting Clonal Evolution of Lung Adenosquamous Carcinoma
Authors: Y. Han, S. Lu, R. Zhao, Y. Xu, Y. Chen, C. Xiang, Q. Wu, S. Chen, J. Pang, Z. Shang, J. Zhao, H. Bao, Y. Shao
Journal: Journal of Thoracic Oncology (2022)
EP08.02-054 Efficacy and Safety of TKI Dose Reduction - Can Less Mean More?
Authors: F. Pereira da Silva, F. Jesus, J. Ribeiro, S. Braga, É. Almeida, R. Natal, M. Tavares, J. Costa, F. Luís, M. Oliveira, L. Ferreira
Journal: Journal of Thoracic Oncology (2022)
EP14.01-022 Immune Thrombocytopenia in a Patient with Large Cell Neuroendocrine Carcinoma Under Dual Immune Checkpoint Inhibition
Authors: G. Gomatou, V. Ramfidis, M. Bakogeorgos, V. Nikolaidou, G. Evangelou, E. Kotteas, I. Gkiozos, A. Papafili, A. Charpidou
Journal: Journal of Thoracic Oncology (2022)
EP08.02-108 Osimertinib Long-Term Tolerability in Patients with EGFRm NSCLC Enrolled in the AURA Program or FLAURA Study
Authors: M.C. Garassino, Y. He, M.-J. Ahn, S. Orlov, V. Potter, T. Kato, J. Laskin, P.J. Voon, T. Reungwetwattana, S. Ramalingam, Y.-L. Wu, M. Albayaty, S. Cross, X. Huang, D. Kulkarni, B.C. Cho
Journal: Journal of Thoracic Oncology (2022)
EP16.03-024 Cellworks Singula™ Therapy Response Index (TRI) Identifies Superior OS Outcomes for NSCLC Patients: myCare-203A
Authors: M. Klein, D. Watson, M. Castro, S. Kapoor, P.R. Nair, S. Rajagopalan, M.D. Macpherson, J. Christie, A. Alam, H. Qin, M. Glaser, D.A. Lala, S.A. Prasad, P. G, Y.S. Ullal, D. Sahu, S. Kulkarni, Y. Narvekar, A. Ghosh, S.R. Choudhury, S. Birajdar, K.G. Roy, D. Singh, C. Kumar, V. Joseph, N. Mundkur, S. Patel, A.K. Ganti
Journal: Journal of Thoracic Oncology (2022)
EP14.01-005 Weekly Sequential ACOCEV Chemotherapy (ADR, CTX, CBDCA, VP16, VCR) for Elderly - Poor PS SCLC Patients: An Observational Study
Authors: A. Santo, F. Lombardo, E. Roca, A. Cucinella, A. Comel, C. Benato, L. Stefanizzi, P. Divis, M. Sposito, S. Vaccari, E. Fedrigo, E. Tosoni, M. Milella
Journal: Journal of Thoracic Oncology (2022)
EP16.02-017 Predictive Value of Peripheral Blood Immune Cell Profiling in EGFR-T790M Mutant Lung Adenocarcinoma
Authors: Y. Liu, M. Wang, X. Hu, L. Wang, H. Chen, W. Li, Y. Feng, L. Zhang, G. Yao, Y. Shi
Journal: Journal of Thoracic Oncology (2022)
EP08.02-086 Randomized Double-blind Placebo-controlled trial of Nicotinamide and EGFR-TKIs for EGFR-mutated Lung Adenocarcinoma
Authors: Y.-C. Kim, I.-J. Oh, C.-K. Park, H.-J. Oh, I.Y. Park, S.-C. Bae
Journal: Journal of Thoracic Oncology (2022)
EP08.01-065 Prevalence of Non-driver Mutations and Characterization of Patients with Advanced or Metastatic Non-small Cell Lung Cancer
Authors: M. Provencio, D. Pérez Parente, H. Hasan, B. Campos Balea, D. Rodríguez Abreu, M. López Brea Piqueras, S. Olson, N. Pal, S. Wilkinson, F. de Oro-Pulido, P. Ruiz Gracia, M. Cobo Dols
Journal: Journal of Thoracic Oncology (2022)
EP16.03-025 Immunogenomics of Clinical Resistance to KRAS G12C Inhibition
Authors: M. Woodcock, Y.S. Tsai, S.H. Azam, L.B. Thorne, K.L. Kanchi, J.S. Parker, B.G. Vincent, C.V. Pecot
Journal: Journal of Thoracic Oncology (2022)
EP03.01-016 The Canadian Small Cell Lung Cancer Database (CASCADE): Results from a Multi-Institutional Real-World Evidence Collaboration
Authors: S.M. Moore, L.J. Zhan, G. Liu, R. Rittberg, D. Patel, D. Chowdhury, B. Leung, S. Cheng, M. Mckinnon, K. Khan, J. Agulnik, A.S. Fung, W.Y. Cheung, S. Snow, D. Dawe, V. Cohen, M. Yan, C. Ho, B.H. Lok, P. Wheatley-Price
Journal: Journal of Thoracic Oncology (2022)
EP08.02-103 Lorlatinib for ALK+ NSCLC Patients Pretreated with Second-Generation ALK Inhibitors: Canadian Real-World Experience
Authors: R. Ng, C. Zuraik, P.V. On, S. Khoudigian, A. Sharma, F. Peloquin, F. Fanton Aita, M. Rupp
Journal: Journal of Thoracic Oncology (2022)
EP16.02-015 Phenotyping Malignant Pleural Effusions with Mass Cytometry: Evidence of EMT and MET States in Late-Stage NSCLC
Authors: L.G. Karacosta, D. Pancirer, J. Preiss, J.B. Shrager, A.W. Sung, J.W. Neal, S.C. Bendall, H. Wakelee, S.K. Plevritis
Journal: Journal of Thoracic Oncology (2022)
EP08.02-065 Response to Systemic Anti-Cancer Therapy in Uncommon EGFR Mutations
Authors: H.M. O'Sullivan, S. MacMahon, N. Cunningham, S. Farag, None P.D. d'Arienzo, C. Milner-Watts, N. Tokaca, M. Davidson, A. Minchom, J. Bhosle, N. Yousaf, W. Cui, M. O'Brien, S. Popat
Journal: Journal of Thoracic Oncology (2022)
EP08.01-006 Using Real World data to build effective predictive machine learining models for NSCLC patients treated with immune-based therapy
Authors: A. prelaj, E.G. Galli, M. Pesenti, G. Viscardi, A. Bottiglieri, R. Marinacci, B. Pedica, C. Proto, R. Ferrara, A. De Toma, M. Brambilla, M. Occhipinti, S. Manglaviti, G. Galli, L. Mazzeo, T. Beninato, C.C. Pircher, M.R. Di Mauro, M. Ganzinelli, A. Di Nucci, A.D. Dumitrascu, S. Di Gregorio, F.M.G. De Braud, M.C. Garassino, M. Restelli, G. Lo Russo, F. Trovo', A.L.G. Pedrocchi
Journal: Journal of Thoracic Oncology (2022)
EP04.02-005 First Comprehensive Lung Cancer Long-Term Survivorship Program - Late Toxicities and Overall Survival
Authors: J.-P.H. Exner, S. Nadjm, R. Hepp de los Rios, M. Metzenmacher, A.-C. Hoffmann, T.C. Gauler, C. Aigner, G. Stamatis, F. Oezkan, C. Schulte, K. Darwiche, C. Taube, D. Theegarten, T. Plönes, C. Poettgen, L. Umutlu, H. Hautzel, M. Schuler, M. Stuschke, W.E.E. Eberhardt
Journal: Journal of Thoracic Oncology (2022)
EP08.01-040 Peripheral Blood Cells as Predictors for Efficacy of Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer
Authors: J. Rogado, F. Pozo, K. Troule, V. Pacheco-Barcia, N. Romero-Laorden, F. Al-Sharour, A. Alfranca, J.M. Sánchez-Torres, R. Colomer
Journal: Journal of Thoracic Oncology (2022)
EP08.02-021 A Phase II Trial of Upfront Aumolertinib (HS-10296) plus Radiotherapy for EGFR Mutated Non-small-cell Lung Cancer Patients with Brain Metastases
Authors: Y. Tang, L. Zhu, M. Zhang, B. Wang, X. Xu, S. Ma, B. Xia
Journal: Journal of Thoracic Oncology (2022)
EP08.02-074 Impact of Germline BRCA1/2 Alterations on EGFR Mutant Advanced Non-small Cell Lung Cancer Outcomes
Authors: J.D. Patel, C. Vekkalagadda, L. Bucheit, C. Weipert, J. Saha, N. Zhang, L. Mezquita
Journal: Journal of Thoracic Oncology (2022)
EP08.01-024 Multicenter Real Life Clinical Outcomes of PDL-1 Tested Patients with Non Small Cell Lung Cancer (NSCLC) in Turkey
Authors: O. Yazici, F. Gürler, R. Acar, M. Gürbüz, D.C. Güven, T. Başoğlu Tüylü, M. Araz, S. Kılıçkap, I. Ertürk, F. Cay Senler, M. Karaağaç, F. Yumuk, A. Demirkazık, E. Şen, R. Yorulmaz Çakmak, N. Karadurmuş, N. Akyürek, S. Turhal, N. Özdemir, A. Özet
Journal: Journal of Thoracic Oncology (2022)
EP08.01-060 Long term Survival Outcomes in NSCLC Patients with Targeted Therapy and Immunotherapy: An IASLC Analysis of ASCO CancerLinQ Discovery Data
Authors: M. Behera, G. Joseph, M. Rupji, Z. Huang, B. Bunn, M. Wynes, J. Switchenko, G. Scagliotti, K. Higgins, M. Tsao, C. Belani, L. Sequist, S.S. Ramalingam
Journal: Journal of Thoracic Oncology (2022)
EP08.01-073 AdvanTIG-105: Phase 1b Dose-Expansion Study of Ociperlimab plus Tislelizumab in Patients with Metastatic NSCLC
Authors: R. Kumar, S.H. Kim, D. Zhong, S. Lu, Y. Cheng, M. Chen, E. Cho, T. Clay, J.-H. Kang, G.-W. Lee, M. Sun, B.-Y. Shim, D.R. Spigel, T.-Y. Yang, Q. Wang, G.-C. Chang, G. Yu, R. Wang, X. Luo, H. Zheng, R. Gao, H.R. Kim
Journal: Journal of Thoracic Oncology (2022)
EP08.01-042 NEPTUNE China Cohort: First-Line Durvalumab + Tremelimumab versus Chemotherapy in Chinese Patients with Metastatic NSCLC
Authors: Y. Cheng, Q. Zhou, B. Han, Y. Fan, L. Shan, J. Chang, S. Sun, J. Fang, Y. Chen, J. Sun, G. Wu, H. Mann, K. Naicker, N. Shire, T. Mok, G. de Castro
Journal: Journal of Thoracic Oncology (2022)
EP02.03-007 Seeds of Gold. Triple Contrast Marking in Hybrid Operative Room for All-in One Diagnostic and Therapeutic Precision Surgery
Authors: E. Della Beffa, M. Calandri, G.L. Rosboch, F. Femia, A. Buttiglieri, C. Gazzera, P.O. Lausi, A. Carmelo, P. Garrone, L. Palmieri, L. Neitzert, P. Lyberis, P. Fonio, E. Ruffini, F. Guerrera
Journal: Journal of Thoracic Oncology (2022)
EP05.01-010 External Validation of Two Prediction Models for Severe Radiation-induced Lymphopenia during Concurrent Chemoradiotherapy for Lung Cancer
Authors: P. van Rossum, B. Stam, C. Juan-Cruz, M.M.G. Rossi, A. Abravan, J.S.a. Belderbos, J.-J. Sonke
Journal: Journal of Thoracic Oncology (2022)
P1.12-04 The FLARE score and circulating neutrophils are associated with poor Covid-19 outcomes in patients with thoracic cancers
Authors: E. Seguí, T. Gorria, E. Auclin, J.M. Torres, D. Casadevall, J. Aguilar-Company, M. Rodríguez, N. Epaillard, J. Gavira, J.C. Tapia, M. Tagliamento, S. Pilotto, R. López-Castro, X. Mielgo, C. Urbano, J. Bautista Blaquier, M.V. Bluthgen, J.N. Minatta, A. Prat, A. Vlagea, L. Mezquita
Journal: Journal of Thoracic Oncology (2022)
P2.12-01 Intratumoral Conventional Type 1 Dendritic Cells (cDC1s) Predict Response to Immunotherapy in Human Non-small Cell Lung Cancer cancer (NSCLC)
Authors: A. Porciuncula, B. Henick, N. Gianino, J. Zugazagoitia, I. Vathiotis, N. Gavrielatou, S. Zacharek, D.L. Rimm, K.A. Schalper
Journal: Journal of Thoracic Oncology (2022)
P2.08-09 Adaptation of Empathic Communication Skills Training for Oncology Care Providers to Reduce Lung Cancer Stigma
Authors: J. Ostroff, S. Banerjee, C. Malling, P. Parker, L. Carter-Harris, N. Emard, M. Shen, T. Williamson, H. Hamann, C. Bylund, J. Studts, M. Rigney, J.C. King, J. Fathi, J. Feldman, J. Pantelas, J. Schiller, A. Borondy-Kitts, E. Kazerooni, T. Mullet, L. Rosenthal, K. Durden
Journal: Journal of Thoracic Oncology (2022)
EP05.01-009 A Clinical Outcome Comparison of IMRT and VMAT in Stage II and III NSCLC Irradiated with Radical Intent
Authors: J. Belderbos, N. Wolfhagen, J. Knegjens, J. van Diessen, P. van Rossum, None k. Smits, R. de Jong, M. Kwint, S. Clevers, R. Haas, B. Stam, T. Janssen, J.-J. Sonke, M. de Jong
Journal: Journal of Thoracic Oncology (2022)
EP05.02-003 Durvalumab after Chemoradiotherapy (CRT) in Unresectable Stage III NSCLC. Comparative Study of Two Cohorts in the Real-World Setting
Authors: B. Tavara, M. Rojas, Z. Rodríguez, M.L. Garrido, L. López, S. Medina, C. Ponte, A. López, E. Sanchez, M. Pedraza, P. Viñals, M. Lopez, D. Alonso, A. Rodríguez, C. Castañon, E. Davila, L.M. De Sande, B. Nieto, M.E. Vallejo Pascual, J.d.l.R. Rodriguez, A. Garcia Palomo, P. Diz Taín
Journal: Journal of Thoracic Oncology (2022)
EP02.01-017 The Role of Adjuvant Chemotherapy for Stage II/III Lung Adenocarcinoma Based on Epidermal Growth Factor Receptor Mutation Status
Authors: Y. Tsutani, Y. Shimada, H. Ito, Y. Miyata, N. Ikeda, H. Nakayama, M. Okada
Journal: Journal of Thoracic Oncology (2022)
EP05.02-008 Phase II Trial of Neoadjuvant Icotinib Plus Chemotherapy for Stage II-IIIB EGFR-mutant Non-small-Cell Lung Cancer
Authors: F.-L. Lu, C. Lv, M.-L. Zhuo, X. Yang, S. Yan, J.-F. Chen, N. Wu
Journal: Journal of Thoracic Oncology (2022)
EP05.01-032 The Incidence of Brain Metastasis and Radiation Pneumonitis With Durvalumab After Chemoradiotherapy in Unresectable Stage III NSCLC
Authors: Y. Kim, Y.-K. Choi, Y.-K. Kwak, Y.-H. Lee, S.-H. Kim, S.-Y. Sung, S.-H. Son
Journal: Journal of Thoracic Oncology (2022)
EP03.01-002 Co-occurring Mutations, Smoking Status and Prognosis of Early-stage Resected NSCLCs with EGFR Mutations
Authors: A. Moore, E. Pianarosa, K. Khan, K. Balaratnam, M.T. Chowdhury, P. Walia, A. Sabouhanian, J. Herman, E. Strom, L. Corke, V. Mai, L.J. Zhan, M.C. Brown, S. Cheng, K. Hueniken, N. Leighl, F. Shepherd, P. Bradbury, A. Sacher, G. Liu, M. Garcia
Journal: Journal of Thoracic Oncology (2022)